Loading...
GeoVax Labs, Inc.
GOVX•NASDAQ
Healthcare
Biotechnology
$0.90
$-0.42(-31.82%)
GeoVax Labs, Inc. (GOVX) Financial Performance & Statements
Review GeoVax Labs, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
5.98%
↑ 5.98%
Net Income Growth
3.75%
↑ 3.75%
Operating Cash Flow Growth
1.98%
↑ 1.98%
Operating Margin
-441.15%
↓ 441.15%
Gross Margin
23.12%
↑ 23.12%
Net Profit Margin
-438.17%
↓ 438.17%
ROE
-511.98%
↓ 511.98%
ROIC
-312.31%
↓ 312.31%
GeoVax Labs, Inc. (GOVX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for GeoVax Labs, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $864415.00 | $2.79M | $300677.00 |
| Cost of Revenue | $0.00 | $21641.00 | $0.00 | $4.28M |
| Gross Profit | $0.00 | $842774.00 | $2.79M | -$3.98M |
| Gross Profit Ratio | $0.00 | $0.97 | $1.00 | -$13.22 |
| R&D Expenses | $5.35M | $7.61M | $7.40M | $4.28M |
| SG&A Expenses | $1.69M | $1.60M | $1.24M | $1.09M |
| Operating Expenses | $7.04M | $9.19M | $8.64M | $5.36M |
| Total Costs & Expenses | $0.00 | -$9.21M | $8.64M | $5.36M |
| Interest Income | $47519.00 | $81748.00 | $53191.00 | $5471.00 |
| Interest Expense | $0.00 | $0.00 | $14083.00 | $7292.00 |
| Depreciation & Amortization | $0.00 | $21641.00 | $30408.00 | $23743.00 |
| EBITDA | -$5.41M | -$8.24M | -$5.77M | -$5.03M |
| EBITDA Ratio | -$9.53 | -$2.07 | -$16.74 | |
| Operating Income | -$5.41M | -$8.34M | -$5.85M | -$5.06M |
| Operating Income Ratio | -$9.65 | -$2.10 | -$16.84 | |
| Other Income/Expenses (Net) | $47519.00 | $81748.00 | $39108.00 | -$1821.00 |
| Income Before Tax | -$5.36M | -$8.26M | -$5.82M | -$5.06M |
| Income Before Tax Ratio | -$9.56 | -$2.08 | -$16.84 | |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$5.36M | -$8.26M | -$5.82M | -$5.06M |
| Net Income Ratio | -$9.56 | -$2.08 | -$16.84 | |
| EPS | -$0.45 | -$1.43 | -$0.91 | -$1.99 |
| Diluted EPS | -$0.45 | -$1.43 | -$0.91 | -$1.99 |
| Weighted Avg Shares Outstanding | $11.95M | $10.54M | $6.40M | $2.54M |
| Weighted Avg Shares Outstanding (Diluted) | $11.95M | $10.54M | $6.40M | $2.54M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan